Faisal Latif
About Faisal Latif
Faisal Latif is the Director of WW Access Marketing, In Region (RoW) at Bristol Myers Squibb in Uxbridge, UK, with extensive experience in health economics and market access.
Title
Faisal Latif is the Director of WW Access Marketing, In Region (RoW) at Bristol Myers Squibb, based in Uxbridge, UK.
Current Role at Bristol Myers Squibb
Faisal Latif currently holds the position of Director, WW Access Marketing, In Region (RoW) at Bristol Myers Squibb. In this role, he leads strategic market access initiatives for Immuno-Oncology therapies across multiple European regions such as Italy, Spain, and the Nordics. He is responsible for optimizing reimbursement strategies for the company's portfolio, excluding Haematology, in Western Europe. His work involves comprehensive engagement with stakeholders to navigate the biopharma environment effectively.
Previous Experience at Bristol Myers Squibb
Before his current role, Faisal Latif served as HEOR Manager at Bristol Myers Squibb from 2016 to 2020. During his tenure, he accumulated significant experience in health economics and outcomes research. His contributions were essential in commercializing transformational medicines aimed at addressing high unmet medical needs.
Consulting Roles
Faisal Latif has an extensive background in consulting. He worked at DRG Abacus as a Consultant from 2014 to 2016 and at WG Consulting as Lead Consultant Health Economist in 2014. Previously, he served as a Consultant Health Economist at Double Helix Consulting from 2010 to 2014. His early consulting roles also include positions at FreshMinds and the Institute of Business Consulting.
Early Career
Faisal Latif began his career in various analytical and auditing roles. He worked as a Business Analyst, SPV Analyst at Credit Suisse, and a Trainee Auditor at KPMG LLP. His earlier roles provided him with a foundation in financial analysis and business consulting.
Education and Expertise
Faisal Latif holds a degree in Neuroscience (BSc Hons) from the University of Nottingham, an MSc in Entrepreneurship, Science & Technology from Nottingham University Business School, and another MSc in International Health Policy (Health Economics) from the London School of Economics and Political Science. He also completed the BMS UK & Ireland Accelerated Leadership Programme Scheme (ALPS) at Ashridge Executive Education, Hult International Business School.